Credit Suisse Sees Solid Q4 Earnings For Kite Pharma
March 27, 2015 at 09:03 AM EDT
In a report published Friday, Credit Suisse analyst Jason Kantor reiterated an Outperform rating and $79.00 price target on Kite ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.